Skip to content

Clinical trials

Phase 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2 Country / region: South Korea Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20081
20102
20111
20141
20151
20191
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status4
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center4
Bristol-Myers Squibb1
Cooperative Study Group A for Hematology1
Ho Joon Im1
Hyoung Jin Kang1
Jae Wook Lee1
Sanofi1
Seoul National University Hospital1
The Catholic University of Korea1
The Korean Society of Pediatric Hematology Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
Leukemia, Myeloid, Acute3
Anemia, Refractory, with Excess of Blasts2
Blast Crisis2
Leukemia2
Leukemia, Biphenotypic, Acute2
Leukemia, Myeloid, Accelerated Phase2
Leukemia, Myeloid, Chronic-Phase2
Leukemia, Myelomonocytic, Chronic2
Myelodysplastic Syndromes2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.